| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 16 |
| 1 | CARBOPLATIN | 15 |
| 2 | PACLITAXEL | 15 |
| 3 | PACLITAXEL (AIBUMIN-BOUND) | 15 |
| 4 | PEMBROLIZUMAB | 14 |
| 5 | ALEMTUZUMAB | 12 |
| 6 | METHYLPREDNISOLONE | 12 |
| 7 | CYCLOPHOSPHAMIDE | 11 |
| 8 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| 9 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ALEMTUZUMAB | 12 | 0.0006 |
| 1 | DAPRODUSTAT | 1 | 0.0005 |
| 2 | GOLIMUMAB | 4 | 0.0003 |
| 3 | PIPERACILLIN AND TAZOBACTAM | 3 | 0.0002 |
| 4 | FINGOLIMOD HYDROCHLORIDE | 1 | 0.0002 |
| 5 | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | 5 | 0.0002 |
| 6 | TOBRAMYCIN SOLUTION | 2 | 0.0002 |
| 7 | TOBRAMYCIN SULFATE | 2 | 0.0002 |
| 8 | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | 3 | 0.0002 |
| 9 | PACLITAXEL | 15 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD52-directed Cytolytic Antibody [EPC] | 12 | 0.0006 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 1 | 0.0004 |
| 2 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 18 | 0.0002 |
| 3 | Central alpha-2 Adrenergic Agonist [EPC] | 6 | 0.0001 |
| 4 | Human Immunoglobulin G [EPC] | 2 | 0.0001 |
| 5 | Microtubule Inhibitor [EPC] | 15 | 0.0001 |
| 6 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 1 | 0.0001 |
| 7 | Provitamin D2 Compound [EPC] | 2 | 0.0001 |
| 8 | Thrombopoietin Receptor Agonist [EPC] | 1 | 0.0001 |
| 9 | Platinum-based Drug [EPC] | 15 | 0.0001 |